Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies.

Gocko X, Lenormand C, Lemogne C, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Jaulhac B, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Caumes E, Dieudonné M, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Saunier A, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Cathebras P, Tattevin P; endorsed by the following scientific societies.

Med Mal Infect. 2019 Jun 27. pii: S0399-077X(19)30620-1. doi: 10.1016/j.medmal.2019.05.006. [Epub ahead of print] No abstract available.

PMID:
31257066
2.

Acute cholangitis: Diagnosis and management.

Sokal A, Sauvanet A, Fantin B, de Lastours V.

J Visc Surg. 2019 Jun 24. pii: S1878-7886(19)30067-0. doi: 10.1016/j.jviscsurg.2019.05.007. [Epub ahead of print]

PMID:
31248783
3.

Unexpected activity of oral fosfomycin against resistant strains of Escherichia coli in murine pyelonephritis.

Pourbaix A, Guérin F, Burdet C, Massias L, Chau F, Cattoir V, Fantin B.

Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00903-19. doi: 10.1128/AAC.00903-19. [Epub ahead of print]

PMID:
31160291
4.

Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis.

Jaulhac B, Saunier A, Caumes E, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Gocko X, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Cathebras P, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Lenormand C, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Lemogne C, Tattevin P; endorsed by scientific societies.

Med Mal Infect. 2019 May 31. pii: S0399-077X(19)30131-3. doi: 10.1016/j.medmal.2019.05.001. [Epub ahead of print] Review.

PMID:
31155367
5.

Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis.

Figoni J, Chirouze C, Hansmann Y, Lemogne C, Hentgen V, Saunier A, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Caumes E, Eldin C, de Broucker T, Jaulhac B, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Gocko X, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Lenormand C, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Cathebras P, Tattevin P; endorsed by scientific societies.

Med Mal Infect. 2019 May 13. pii: S0399-077X(19)30116-7. doi: 10.1016/j.medmal.2019.04.381. [Epub ahead of print] Review.

PMID:
31097370
6.

Surgery is safe and effective when indicated in the acute phase of hematogenous pyogenic vertebral osteomyelitis.

Canouï E, Zarrouk V, Canouï-Poitrine F, Desmoulin U, Leflon V, Allaham W, de Lastours V, Guigui P, Fantin B.

Infect Dis (Lond). 2019 Apr;51(4):268-276. doi: 10.1080/23744235.2018.1562206. Epub 2019 Feb 7.

PMID:
30729831
7.

Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.

Alexandre K, Soares A, Chau F, Fantin B, Caron F, Etienne M.

J Antimicrob Chemother. 2019 Jan 25. doi: 10.1093/jac/dky569. [Epub ahead of print]

PMID:
30689887
8.

A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.

Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S; R-Gnosis WP3 study group.

Clin Microbiol Infect. 2019 Jul;25(7):830-838. doi: 10.1016/j.cmi.2018.12.009. Epub 2019 Jan 4.

9.

[Insights on the management of Lyme disease].

Feyeux D, Fantin B.

Rev Med Interne. 2019 Apr;40(4):226-231. doi: 10.1016/j.revmed.2018.11.014. Epub 2018 Dec 23. French.

PMID:
30587410
10.

Prediction of the intestinal resistome by a three-dimensional structure-based method.

Ruppé E, Ghozlane A, Tap J, Pons N, Alvarez AS, Maziers N, Cuesta T, Hernando-Amado S, Clares I, Martínez JL, Coque TM, Baquero F, Lanza VF, Máiz L, Goulenok T, de Lastours V, Amor N, Fantin B, Wieder I, Andremont A, van Schaik W, Rogers M, Zhang X, Willems RJL, de Brevern AG, Batto JM, Blottière HM, Léonard P, Léjard V, Letur A, Levenez F, Weiszer K, Haimet F, Doré J, Kennedy SP, Ehrlich SD.

Nat Microbiol. 2019 Jan;4(1):112-123. doi: 10.1038/s41564-018-0292-6. Epub 2018 Nov 26.

PMID:
30478291
11.

[The value of fecal calprotectin assay in chronic panniculitis of unknown etiology].

Kaddour K, Lemasson J, Haettich-Pialoux B, Guedj N, Belmatoug N, Treton X, Becheur H, Fantin B, Descamps V, Le Bozec P.

Ann Dermatol Venereol. 2018 Nov;145(11):702-705. doi: 10.1016/j.annder.2018.07.018. Epub 2018 Sep 25. French. No abstract available.

PMID:
30266304
12.

Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.

Berleur M, Guérin F, Massias L, Chau F, Poujade J, Cattoir V, Fantin B, de Lastours V.

J Antimicrob Chemother. 2018 Nov 1;73(11):3074-3080. doi: 10.1093/jac/dky283.

PMID:
30085154
13.

Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France.

Cheminet G, Kapel N, Bleibtreu A, Sadou-Yaye H, Bellanger A, Duval X, Joly F, Fantin B, de Lastours V; French Group for Fecal Microbiota Transplantation (GFTF).

J Hosp Infect. 2018 Oct;100(2):148-151. doi: 10.1016/j.jhin.2018.07.005. Epub 2018 Aug 11. No abstract available.

PMID:
30009869
14.

An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.

Miguel Montanes R, Elkrief L, Hajage D, Houssel P, Fantin B, Francoz C, Dreyfuss D, Ricard JD, Durand F.

Transpl Infect Dis. 2018 Oct;20(5):e12956. doi: 10.1111/tid.12956. Epub 2018 Jul 2.

PMID:
29896781
15.

Increased mortality in patients aged 75 years or over with pyogenic vertebral osteomyelitis.

Zarrouk V, Gras J, Dubée V, de Lastours V, Lopes A, Leflon V, Allaham W, Guigui P, Fantin B.

Infect Dis (Lond). 2018 Oct;50(10):783-787. doi: 10.1080/23744235.2018.1470667. Epub 2018 May 10. No abstract available.

PMID:
29745282
16.

Flagellate erythema in systemic sclerosis: A case report.

Jannic A, Maillet J, Rossi B, Guedj N, Descamps V, Fantin B, Le Bozec P.

JAAD Case Rep. 2018 Feb 23;4(3):239-241. doi: 10.1016/j.jdcr.2017.09.013. eCollection 2018 Apr. No abstract available.

17.

[Influenzae and pneumococcal vaccination rate in an internal medicine ward].

Goulenok T, Chopin D, De Lastours V, Zarrouk V, Lepeule R, Fantin B, Lefort A.

Rev Med Interne. 2018 Jun;39(6):386-392. doi: 10.1016/j.revmed.2018.02.020. Epub 2018 Mar 20. French.

PMID:
29571580
18.

Hypervirulent Klebsiella pneumoniae in Cryptogenic Liver Abscesses, Paris, France.

Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G, Dokmak S, Ronot M, Roux O, Nicolas-Chanoine MH, Fantin B, Lefort A.

Emerg Infect Dis. 2018 Feb;24(2):221-229. doi: 10.3201/eid2402.170957.

19.

Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.

de Lastours V, Goulenok T, Guérin F, Jacquier H, Eyma C, Chau F, Cattoir V, Fantin B.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):417-421. doi: 10.1007/s10096-018-3186-x. Epub 2018 Jan 10.

PMID:
29318461
20.

Effect of a Red Blood Cell Transfusion on Biological Markers Used to Determine the Cause of Anemia: A Prospective Study.

Froissart A, Rossi B, Ranque B, Jarrin I, Bergmann JF, Beaune S, Dautheville S, Breau N, Dauvergne A, Deluche L, Robert T, Gault N, Roy C, Zarrouk V, Steichen O, Fantin B; SiFMI group.

Am J Med. 2018 Mar;131(3):319-322. doi: 10.1016/j.amjmed.2017.10.005. Epub 2017 Oct 20.

PMID:
29061498
21.

Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.

Pourbaix A, Guérin F, Lastours V, Chau F, Auzou M, Boulley E, Cattoir V, Fantin B.

Int J Med Microbiol. 2017 Dec;307(8):452-459. doi: 10.1016/j.ijmm.2017.09.019. Epub 2017 Sep 29.

PMID:
28986014
22.

Pharmacokinetics and Pharmacodynamics of Temocillin.

Alexandre K, Fantin B.

Clin Pharmacokinet. 2018 Mar;57(3):287-296. doi: 10.1007/s40262-017-0584-7. Review.

PMID:
28849402
23.

Cytomegalovirus-associated protein-losing enteropathy in a healthy man.

Perrineau S, Cazals-Hatem D, Zarrouk V, Fantin B, de Lastours V.

Med Mal Infect. 2017 Dec;47(8):562-565. doi: 10.1016/j.medmal.2017.07.003. Epub 2017 Aug 9. No abstract available.

PMID:
28802763
24.

Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study.

Lemaignen A, Ghout I, Dinh A, Gras G, Fantin B, Zarrouk V, Carlier R, Loret JE, Denes E, Greder A, Lescure FX, Boutoille D, Tattevin P, Issartel B, Cottier JP, Bernard L; DTS (Duration of Treatment for Spondylodiscitis) study group.

Medicine (Baltimore). 2017 May;96(21):e6387. doi: 10.1097/MD.0000000000006387.

25.

Autochthonous Case of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, France, 2016.

Nguyen Y, Rossi B, Argy N, Baker C, Nickel B, Marti H, Zarrouk V, Houzé S, Fantin B, Lefort A.

Emerg Infect Dis. 2017 Jun;23(6):1045-1046. doi: 10.3201/eid2306.161999.

26.

Guidelines on the management of infectious encephalitis in adults.

Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P; reviewing group.

Med Mal Infect. 2017 May;47(3):179-194. doi: 10.1016/j.medmal.2017.01.005. Epub 2017 Apr 12. No abstract available.

PMID:
28412044
27.

Management of adult infectious encephalitis in metropolitan France.

Goulenok T, Buzelé R, Duval X, Bruneel F, Stahl JP, Fantin B.

Med Mal Infect. 2017 May;47(3):206-220. doi: 10.1016/j.medmal.2017.01.006. Epub 2017 Mar 20. Review.

PMID:
28336304
28.

Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.

de Lastours V, Maugy E, Mathy V, Chau F, Rossi B, Guérin F, Cattoir V, Fantin B; CIPHARES Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1574-1580. doi: 10.1093/jac/dkx043.

PMID:
28333351
29.

[Liver abscess].

Rossi G, Lafont E, Gasperini L, Dokmak S, Ronot M, Rossi B, Zarrouk V, Fantin B, Lefort A.

Rev Med Interne. 2016 Dec;37(12):827-833. doi: 10.1016/j.revmed.2016.08.009. Epub 2016 Sep 14. French.

PMID:
27639909
30.

Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.

de Lastours V, Chopin D, Jacquier H, d'Humières C, Burdet C, Chau F, Denamur E, Fantin B.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6941-6944. doi: 10.1128/AAC.01328-16. Print 2016 Nov.

31.

Medical complications following splenectomy.

Buzelé R, Barbier L, Sauvanet A, Fantin B.

J Visc Surg. 2016 Aug;153(4):277-86. doi: 10.1016/j.jviscsurg.2016.04.013. Epub 2016 Jun 8. Review.

PMID:
27289254
32.

Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.

Audemard-Verger A, Descloux E, Ponard D, Deroux A, Fantin B, Fieschi C, John M, Bouldouyre A, Karkowsi L, Moulis G, Auvinet H, Valla F, Lechiche C, Davido B, Martinot M, Biron C, Lucht F, Asseray N, Froissart A, Buzelé R, Perlat A, Boutboul D, Fremeaux-Bacchi V, Isnard S, Bienvenu B.

Medicine (Baltimore). 2016 May;95(19):e3548. doi: 10.1097/MD.0000000000003548.

33.

Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.

Alexandre K, Chau F, Guérin F, Massias L, Lefort A, Cattoir V, Fantin B.

J Antimicrob Chemother. 2016 Jul;71(7):1899-904. doi: 10.1093/jac/dkw066. Epub 2016 Mar 29.

PMID:
27029848
34.

Presentation and impact of catheter-associated thrombosis in patients with infected long-term central venous catheters: a prospective bicentric observational study.

Galy A, Lepeule R, Goulenok T, Buzele R, de Lastours V, Fantin B.

Ann Med. 2016;48(3):182-9. doi: 10.3109/07853890.2016.1154981. Epub 2016 Mar 29.

PMID:
27022769
35.

[What future for the prescriptions of fluoroquinolones?]

De Lastours V, Fantin B.

Rev Prat. 2016 Mar;66(3):239-244. French. No abstract available.

PMID:
30512630
36.

Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC.

BMJ Open. 2016 Jan 29;6(1):e009029. doi: 10.1136/bmjopen-2015-009029.

37.

[Pyogenic brain abscesses in adults].

de Lastours V, Fantin B.

Rev Med Interne. 2016 Jun;37(6):412-7. doi: 10.1016/j.revmed.2015.11.010. Epub 2016 Jan 8. French.

PMID:
26775642
38.

qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis.

Jayol A, Janvier F, Guillard T, Chau F, Mérens A, Robert J, Fantin B, Berçot B, Cambau E.

J Antimicrob Chemother. 2016 Apr;71(4):903-8. doi: 10.1093/jac/dkv431. Epub 2016 Jan 7.

PMID:
26747095
39.

Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.

Rossi B, Soubirou JF, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):424-30. doi: 10.1128/AAC.02018-15. Print 2016 Jan.

40.

Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment.

Munier AL, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R.

Int J Antimicrob Agents. 2015 Dec;46(6):653-9. doi: 10.1016/j.ijantimicag.2015.09.004. Epub 2015 Oct 9.

PMID:
26508586
41.

Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.

de Lastours V, Fantin B.

Future Microbiol. 2015;10(7):1241-55. doi: 10.2217/fmb.15.40. Epub 2015 Jun 29. Review.

PMID:
26119580
42.

[Starvation ketosis in a breastfeeding woman].

Monnier D, Goulenok T, Allary J, Zarrouk V, Fantin B.

Rev Med Interne. 2015 Dec;36(12):854-8. doi: 10.1016/j.revmed.2015.03.011. Epub 2015 Apr 23. French.

PMID:
25912080
43.

Characteristics of vertebral osteomyelitis after liver transplantation.

Buzelé R, Zarrouk V, Francoz C, Durand F, Fantin B.

Clin Microbiol Infect. 2015 Jun;21(6):573-7. doi: 10.1016/j.cmi.2015.01.018. Epub 2015 Jan 28.

44.

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.

Soubirou JF, Rossi B, Couffignal C, Ruppé E, Chau F, Massias L, Lepeule R, Mentre F, Fantin B.

J Antimicrob Chemother. 2015 May;70(5):1466-72. doi: 10.1093/jac/dku542. Epub 2015 Jan 5.

PMID:
25564564
45.

Invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients.

Pierre I, Zarrouk V, Noussair L, Molina JM, Fantin B.

Int J Infect Dis. 2014 Dec;29:74-9. doi: 10.1016/j.ijid.2014.06.012. Epub 2014 Oct 24.

46.

[Investigation and management of genito-urinary tuberculosis].

Fillion A, Koutlidis N, Froissart A, Fantin B.

Rev Med Interne. 2014 Dec;35(12):808-14. doi: 10.1016/j.revmed.2014.07.006. Epub 2014 Sep 17. Review. French.

PMID:
25240482
47.

Behcet's disease in Budd-Chiari syndrome.

Desbois AC, Rautou PE, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, de Chambrun MP, Cacoub P, Valla D, Saadoun D, Plessier A.

Orphanet J Rare Dis. 2014 Sep 13;9:104. doi: 10.1186/s13023-014-0153-1. eCollection 2014.

48.

Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.

de Lastours V, Chau F, Roy C, Larroque B, Fantin B.

J Antimicrob Chemother. 2014 Dec;69(12):3393-400. doi: 10.1093/jac/dku283. Epub 2014 Jul 24.

PMID:
25063781
49.

Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model.

Vigan M, Stirnemann J, Caillaud C, Froissart R, Boutten A, Fantin B, Belmatoug N, Mentré F.

Orphanet J Rare Dis. 2014 Jun 30;9:95. doi: 10.1186/1750-1172-9-95.

50.

[Infections associated with orthopaedic devices].

Dubée V, Zeller V, Fantin B.

Rev Prat. 2014 May;64(5):643-50. French.

PMID:
24923048

Supplemental Content

Loading ...
Support Center